Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Open Access
- 15 December 1993
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 90 (24), 11924-11928
- https://doi.org/10.1073/pnas.90.24.11924
Abstract
It has been reported that soluble interleukin (IL)-6 receptor (sIL-6R) is detected in the serum of healthy individuals and its level is increased in patients with multiple myeloma and human immunodeficiency virus infection. Although several reports have suggested that sIL-6R potentiates IL-6 action, its physiological role remains unclear. In this study, we examined the role of sIL-6R on osteoclast formation by IL-6, using a coculture of mouse osteoblasts and bone marrow cells. Neither recombinant mouse IL-6 (mIL-6) nor mouse sIL-6R (smIL-6R) induced osteoclast-like multinucleated cell (MNC) formation when they were added separately. In contrast, simultaneous treatment with mIL-6 and smIL-6R strikingly induced MNC formation. These MNCs satisfied major criteria of authentic osteoclasts, such as tartrate-resistant acid phosphatase (TRAP) activity, calcitonin receptors, and pit formation on dentine slices. The MNC formation induced by mIL-6 and smIL-6R was dose-dependently inhibited by adding monoclonal anti-mouse IL-6R antibody (MR16-1). It is likely that osteoblasts and osteoclast progenitors are capable of transducing a signal from a complex of IL-6 and sIL-6R through gp130, even though they may have no or a very small number of IL-6Rs. Factors such as IL-11, oncostatin M, and leukemia inhibitory factor, which are known to exert their functions through gp130 (the signal-transducing chain of IL-6R), also induced MNC formation in our coculture system. These results suggest that increased circulating or locally produced sIL-6R induces osteoclast formation in the presence of IL-6 mediated by a mechanism involving gp130. This may play an important physiological or pathological role in conditions associated with increased osteoclastic bone resorption.Keywords
This publication has 32 references indexed in Scilit:
- New resorption assay with mouse osteoclast-like multinucleated cells formed in vitroJournal of Bone and Mineral Research, 1993
- Preparation and characterization of a mouse osteoclast-like multinucleated cell populationJournal of Bone and Mineral Research, 1992
- Increased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6Science, 1992
- Perspectives: Interleukin-6: An osteotropic factor?Journal of Bone and Mineral Research, 1992
- Interleukin-6 does not stimulate bone resorption in neonatal mouse calvariaeJournal of Bone and Mineral Research, 1991
- IL 3 and IL 6 do not induce bone resorption in vitroCytokine, 1990
- Soluble cytokine receptors are present in normal human urine.The Journal of Experimental Medicine, 1989
- Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130Cell, 1989
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988